Patent Diagnostische Marker für die Bestimmung der Prädisposition der Entwicklung von Gebärmutterhalskrebs und für die…

Basic data

Title:
Diagnostische Marker für die Bestimmung der Prädisposition der Entwicklung von Gebärmutterhalskrebs und für die Bestimmung eingesetzte Oligonukleotide
Reference number (DPMA):
10 2009 021 734.7
Primary registration:
12/05/2009
Approval:
02/02/2012

Inventors

Institute of Medical Virology and Epidemiology of Viral Diseases
Department of Diagnostic Laboratory Medicine, Hospitals and clinical institutes, Faculty of Medicine
Manawapat, Anna
formerly Universität Tübingen
Institute of Medical Virology and Epidemiology of Viral Diseases
Department of Diagnostic Laboratory Medicine, Hospitals and clinical institutes, Faculty of Medicine
Københavns Universitet
Kopenhagen, Denmark

Local organizational units

Institute of Medical Virology and Epidemiology of Viral Diseases
Department of Diagnostic Laboratory Medicine
Hospitals and clinical institutes, Faculty of Medicine

National patents

PCT Registration

Registration date:
12/05/2010
Registration number:
PCT/EP2010/056595

Nationalizations

Patent familiy:
10 2009 021 734.7, US137294,905, US147071,470, EP20100718615, CA2761860, AU2010247333

US137294,905
USA: United States Patent and Trademark Office
11/11/2011
04/03/2014 (expired)
US147071,470
USA: United States Patent and Trademark Office
04/11/2013
18/06/2015 (expired)
EP20100718615
European Patent Office
12/05/2010
25/05/2016 (expired)
CA2761860
Kanada: Canadian Intellectual Property Office
12/05/2010
12/05/2016 (expired)
AU2010247333
Australien: IP Australia
15/11/2011
26/11/2015 (expired)
Help

will be deleted permanently. This cannot be undone.